Imperative Care, Inc., a Campbell, Calif. – based company focused on advancing neurovascular devices treating ischemic and hemorrhagic strokes, completed the initial closing of a Series C financing of $85m.
The round was co-led by new investors Ally Bridge Group and Bain Capital Life Sciences with participation from existing investors Ascension Ventures, Delos Capital, Rock Springs Capital, 3H Health Investment, and Incept LLC. In conjunction with the funding, Frank Yu, Ally Bridge’s founder, and Andrew Hack, M.D., Ph.D., Managing Director of Bain Capital, will join Imperative Care’s Board of Directors.
The company intends to use the funds for the commercial launch of its portfolio of devices.
Co-founded in 2016 by Dr. Nick Hopkins, a pioneer of endovascular neurointervention and founder and Chief Scientific Officer of Jacobs Institute, and Fred Khosravi, a medtech entrepreneur and innovator, Imperative Care is developing a portfolio of advancing medical technology solutions to address needs in stroke care. The company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its family of access catheters designed to facilitate consistent navigation into blood vessels of the brain. They have also received FDA clearance for its ZOOM Aspiration System, a family of products designed to facilitate clot removal during ischemic stroke.